Distinguished Scientist
Genentech
Prashant Desai is a Distinguished Scientist at Genentech and leads the in silico predictive ADME group within DMPK. Before joining Genentech in 2022, Prashant served as a Senior Director in the ADME department of Eli Lilly and Company, re-sponsible for in silico and in vitro modeling groups namely, Computational ADME, Mechanistic PK and Investigational Drug Disposition. Prashant has been working in the field of in silico, in vitro and in vivo ADME for the past 16+ years. He was a co-founder and is currently the co-chair of the In Silico ADME WG of the IQ consor-tium. As a scientific leader in the preclinical ADME research, Prashant’s primary focus has been on effective integration of in silico, in vitro, and in vivo ADME models during the early phase of drug discovery in line with the mechanistic pharmacokinetics principles. He received BS in Pharmacy, MS in medicinal chemistry and PhD in Bi-ophysics and Computational Chemistry. He has contributed to more than 60 papers in peer reviewed journals and book chapters.
Disclosure(s): Genentech/Roche: Employment (Ongoing)